MedPath

Ceftazidime

Ceftazidime for Injection, USP

Approved
Approval ID

22d6534c-4488-48a1-8d78-e2fb908259de

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 23, 2021

Manufacturers
FDA

WG Critical Care, LLC

DUNS: 829274633

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ceftazidime

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code44567-237
Application NumberANDA062640
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ceftazidime
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 1, 2021
FDA Product Classification

INGREDIENTS (2)

CEFTAZIDIMEActive
Quantity: 6 g in 100 mL
Code: 9M416Z9QNR
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 100 mL
Code: 2LQ0UUW8IN
Classification: CNTM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ceftazidime - FDA Drug Approval Details